KalVista Pharmaceuticals News

KalVista Pharmaceuticals | 8-K: Current report

Apr 22 16:58 ET

KalVista Pharmaceuticals | 8-K: KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update

Mar 11 16:45 ET

KalVista Pharmaceuticals | 8-K: Current report

Mar 7 06:39 ET

KalVista Pharmaceuticals | 8-K: Current report

Feb 16 16:40 ET

KalVista Pharmaceuticals | 8-K: Current report

Feb 14 17:48 ET

KalVista Pharmaceuticals | 8-K: Current report

Feb 13 06:59 ET

KalVista Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 9 00:00 ET

KalVista Pharmaceuticals | 8-K: KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update

Dec 7, 2023 16:17 ET

KalVista Pharmaceuticals | 8-K: Current report

Sep 28, 2023 16:07 ET

KalVista Pharmaceuticals | 8-K: KalVista Pharmaceuticals Reports First Fiscal Quarter Results and Provides Operational Update

Sep 7, 2023 16:35 ET

KalVista Pharmaceuticals | DEFA14A: Others

Aug 14, 2023 16:11 ET

KalVista Pharmaceuticals | DEF 14A: Definitive information statements

Aug 14, 2023 16:07 ET

KalVista Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Aug 4, 2023 16:05 ET

KalVista Pharmaceuticals | 8-K: Current report

Jul 7, 2023 19:10 ET

KalVista Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jun 20, 2023 16:13 ET

KalVista Pharmaceuticals | 8-K: Current report

Jun 14, 2023 16:30 ET

KalVista Pharmaceuticals | 8-K: KalVista Pharmaceuticals Reports Third Fiscal Quarter Results

Mar 9, 2023 16:24 ET

KalVista Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 10, 2023 16:13 ET

KalVista Pharmaceuticals | 8-K: Current report

Jan 5, 2023 16:12 ET

KalVista Pharmaceuticals | 8-K: Current report

Dec 27, 2022 06:42 ET